JAG Growth Equity Thematic Insights: Q4 2024
December 2024 How to Invest in Concentrated Markets In our previous Insights pieces, we’ve explored key market themes, including the emergence of Generative AI and the growing impact of GLP-1 drugs on healthcare and consumer products. In this write-up, we will discuss a topic that has been garnering considerable attention – market returns being driven […]
JAG Fixed Income Thematic Insights: Q4 2024
December 2024 Summary Clients often ask us which corporate sectors, credit tiers, or tenors of the yield curve our team finds attractive. These are reasonable questions routinely addressed by fixed income managers. We tend to reframe the premise when asked ourselves. Rather than assigning outlooks to categorized segments, we prefer to identify those segments where […]
JAG Growth Equity Thematic Insights: Q3 2024
September 2024 Summary We have extensively covered Gen AI developments in our previous Insights pieces and Q2 earnings season commentary was consistent with our expectations. Almost all of the world’s largest companies continue to prioritize AI infrastructure buildout. For example, Microsoft’s (MSFT) most recent quarterly capex was $19B and management noted that “cloud and AI-related […]
JAG Growth Equity Thematic Insights: Q2 2024
June 2024 Summary “Creative destruction” is a feature of capitalism and the modern global economy. The forces of innovation push society forward and ultimately result in better products and services for consumers. For investors, the rise of diabesity medications and Artificial Intelligence present opportunities as well as risks. Read more to learn how we are […]
JAG Team Insights — Q1 2024: Thematic Insights
April 2024 Summary Esteemed investor Howard Marks once said, “We may never know where we’re going, but we sure out to know where we are.” We agree with Mr. Marks. What follows is a brief overview of several of JAG’s Growth Portfolio Themes. Artificial Intelligence Secures Its Place GLP-1’s – A Disruptive Force in Medicine […]
TWST’s Interview with JAG CEO/CIO Norm Conley “Magnificent Seven Could Continue to Dominate for a Long Time”
December 14, 2023 — Learn about JAG’s history, investment philosophy, stock selection process, favorite investments, 2023 performance, and our 2024 Outlook… TWST: For the benefit of readers, give us an introduction to JAG Capital Management. Mr. Conley: The roots of our firm go back all the way to 1945. We’ve been known as JAG Capital […]
JAG Team Insights — Getting (Re) Familiar with Discount Bonds
November 15, 2023 Summary Rising interest rates have led to steep price declines in bond markets. Some bonds trade at deep price discounts even though their issuer’s credit quality remains strong. Bonds purchased at a market discount may offer a unique tax-deferral opportunity for investors. Read more…
JAG Team Insights — Fixing Your Fixed Income Allocation: Back to Basics
September 30, 2023 Capital markets have been put through the wringer since the Fed started their rake hike cycle, resulting in many fixed income portfolios failing to achieve their stabilizing role in investors’ asset allocations. The Fed, by its own admission, was late recognizing the severity and persistence of inflation. Behind the curve, but determined […]
JAG Team Insights — Obesity Drug Craze Approaching Critical Milestone
June 2023 In recent years, a class of drugs known as GLP-1 agonists have experienced an unprecedented rise in popularity and captured the attention of doctors, patients, and investors alike. GLP-1 is short for glucagon-like peptide 1, a natural hormone produced by the human body which the drugs are designed to mimic. For the general […]
JAG Team Insights — The AI Revolution: Key Takeaways from Quarterly Earnings Calls
June 2023 As we discussed in our Inaugural piece on AI, we believe the recent acceleration of Artificial Intelligence (AI) is the most disruptive development since the dawn of the Internet itself. We will see more use cases of generative AI as the technology continues to improve at a rapid pace. Generative AI refers to […]